Arcellx · 1 week ago
Director, Value, Evidence & Outcomes Liaison (VEOL) – Northeast & East Central
United States
Full-time
Hybrid
Director/Executive
$215K/yr - $245K/yr
7+ years expArcellx is a public, clinical-stage biotechnology company focused on innovative immunotherapies for cancer treatment. The Director, Value, Evidence & Outcomes Liaison will engage with population-based decision makers to enhance patient access to therapies and improve healthcare delivery through health economic and outcomes research.
BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Responsibilities
Deliver and utilize clinical, value, and outcomes evidence including observational research, comparative effectiveness, and economic data to address customer needs
Synthesize, communicate, and translate complex information packages and/or data into transparent, relevant, objective and actionable insights for value-based decision makers
Collaborate with PHDMs within an assigned geographic "healthcare ecosystem" to understand and address their information needs
Develop and execute the RWE/HEOR strategy collaborating with internal and field-based medical and commercial partners to deliver outstanding customer experiences
Share expertise with customers as their trusted resource on topics related to disease state, Arcellx and competitor products, health outcomes research, quality measures, healthcare policy, technology assessment, economic dynamics, and real-world evidence
Establish valued relationships with PHDMs within assigned accounts at the hospital and payer level
Build and maintain understanding of access landscape, including P&T formulary inclusion, pathway development, payer medical policy coverage, and emerging competitive trends
Collaborate with relevant internal stakeholders to incorporate access insights into account planning
Apply knowledge of clinical, analytic, environmental, and account-level considerations to facilitate mutually beneficial research collaborations
Frequently share customer insights, evidence gaps, environmental trends, and stakeholder evidence needs internally to influence evidence generation and other strategic efforts
Build proactive, RWE/HEOR relationships that lead to innovative collaborations
Maintain deep market and customer knowledge in an increasingly complex and dynamic healthcare ecosystem
Stay abreast of emerging science, environmental trends, healthcare policy, and regulatory actions relevant to US value-based decision-makers
Serve as a knowledgeable resource for customers and internal partners on relevant disease states and therapeutic landscapes, HEOR and RWE, value-based care, the payer perspective, access/reimbursement policy landscape, and value assessment in the US
Qualification
Required
Advanced degree (PharmD, MD, PhD, MS, MSN, MPH) and 7+ years of experience in a scientific or health-related field, including oncology/hematology experience and field-based customer-facing roles in industry
Deep understanding of the US healthcare system and US value-based decision makers
Ability to analyze and effectively communicate study findings on a range of clinical and HEOR topics
Strong comprehension and communication skills, including the ability to translate and present complex scientific information in a clear, concise manner
Experience working with or supporting value-based decision makers
Experience in data analytics and/or HEOR research/application
Demonstrated expertise in HEOR (including observational and pharmacoeconomic research) and value assessment which may include experience using real-world data, AMCP Dossiers, FDAMA 114, and pharmacoeconomic models
Benefits
100% coverage for medical, dental and vision for team members and dependents
Unlimited vacation
A 3-day weekend every month
Fully-paid parental leave for up to 6 months
Tuition reimbursement
401k employer contribution
Relocation assistance for roles if required
Company
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
51-200 employees
H1B Sponsorship
Arcellx has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (4)
2022 (2)
Funding
Current Stage
Public CompanyTotal Funding
$622MKey Investors
Kite Pharma
2023-11-15Post Ipo Equity· $200M
2022-12-09Post Ipo Equity· $100M
2022-06-15Post Ipo Equity· $112M
Leadership Team
Michelle Gilson
Chief Financial Officer
Brad Gliner
Vice President, Clinical Research and Regulatory Affairs
Recent News
2025-12-11
2025-12-08
Company data provided by crunchbase